Inloggad som:

DAHLIA

Är du som patient intresserad av mer information om en studie, kontakta din behandlande läkare.

DAHLIA
A RANDOMIZED, DOUBLE-BLIND, ACTIVE-CONTROLLED PHASE 3 STUDY EVALUATING THE EFFICACY AND SAFETY OF ABP 959 COMPARED WITH ECULIZUMAB IN ADULT SUBJECTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH)
A RANDOMIZED, DOUBLE-BLIND, ACTIVE-CONTROLLED PHASE 3 STUDY EVALUATING THE EFFICACY AND SAFETY OF ABP 959 COMPARED WITH ECULIZUMAB IN ADULT SUBJECTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH)
PLACEHOLDER
Mer information om studien för vårdgivare
Behandling
Fas 3
Kurativ
Företag

Studien ändrades senast av: studysonia (2022-05-04)

Tillbaka till listan